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The binding of a series of benzoxazole analogs with different amide- and ester-linked side
chains to duplex DNA in the absence and presence of divalent metal cations is examined. All
ligands were found to form complexes with Ni2, Cu2, and Zn2, with 2:1 ligand/metal
cation binding stoichiometries dominating for ligands containing shorter side chains ( 2, 6, 7,
and 8), while 1:1 complexes were the most abundant for ligands with long side chains ( 9, 10,
and 11). Ligand binding with duplex DNA in the absence of metal cations was assessed, and
the long side-chain ligands were found to form low abundance complexes with 1:1 ligand/
DNA binding stoichiometries. The ligands with the shorter side chains only formed DNA
complexes in the presence of metal cations, most notably for 7 and 8 binding to DNA in the
presence of Cu2. The binding of long side-chain ligands was enhanced by Cu2 and to a lesser
degree by Ni2 and Zn2. The cytotoxicities of all of the ligands against the A549 lung cancer
and MCF7 breast cancer cell lines were also examined. The ligands exhibiting the most
dramatic metal-enhanced DNA binding also demonstrated the greatest cytotoxic activity. Both
7 and 8 were found to be the most cytotoxic against the A549 lung cancer cell line and 8
demonstrated moderate cytotoxicity against MCF7 breast cancer cells. Metal ions also
enhanced the DNA binding of the ligands with the long side chains, especially for 9, which also
exhibited the highest level of cytotoxicity of the long side-chain compounds. (J Am Soc Mass
Spectrom 2008, 19, 209–218) © 2008 American Society for Mass SpectrometryThe discovery of the selective cytotoxic activity ofUK-1 [1–3], a bis(benzoxazole) isolated as a sec-ondary metabolite from Streptomyces, has stimu-
lated the development of other benzoxazole and benz-
imidazole compounds with similar anticancer activities
[4–6]. As a topoisomerase II inhibitor, one of the unique
properties of UK-1 is its ability to bind biologically
important divalent metal cations [3] and its metal-
mediated DNA binding [3, 7]. While UK-1 has demon-
strated cytotoxicity against a number of cell lines, it
does not inhibit the growth of bacteria, yeast, or fungi
[1, 8], making the mechanism of this selective cytotoxic
activity and the metal binding properties of UK-1 and
new analogs of great interest.
In a recent study, we used electrospray ionization
mass spectrometry (ESI-MS) in conjunction with cyto-
toxicity assays to examine several simple analogs of
UK-1 to explore the metal ion binding requirements of
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doi:10.1016/j.jasms.2007.05.009these compounds, assess metal-mediated DNA binding
and evaluate anticancer and antibacterial activity [6].
Interestingly, the only ligand that exhibited anticancer
activity, 2 (Figure 1), was also the only metal-mediated
DNA binder with a preference for Ni2 as determined
by ESI-MS experiments. Two other compounds, 4 and 5,
formed complexes with DNA in a nonspecific, nonmetal-
mediated manner, and showed antibacterial but not
cytotoxic behavior. These results suggested a correla-
tion between metal-mediated binding and anticancer
activity of the compounds. To improve upon the solu-
bility of the benzoxazoles in aqueous solutions and to
allow further examination of the metal-mediated DNA
binding and anticancer activity, a series of analogs of 2
have been synthesized with different ester and amide-
linked side chains (Figure 1) [9].
In the present study, ESI-MS was used to screen the
binding of the new ligands to a series of divalent metals
including Mg2, Ni2, Cu2, and Zn2. Ligand binding
to duplex DNA in the presence and absence of metal
ions was also assessed. ESI-MS has been shown to be a
useful tool for the analysis of noncovalent ligand/DNA
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tion, and fast analysis times that make it amenable to
high throughput screening [10–12]. Early studies fo-
cused on examining well-studied, commercially avail-
able duplex DNA-binding compounds including both
minor groove binders [13–16] and intercalators [17–19]
to establish that the binding stoichiometries, selectivi-
ties, and specificities observed by ESI-MS correlate with
known solution behavior. More recent studies have
extended the use of the technique to novel compounds,
including studies by our group examining the metal-
dependent binding of UK-1 and related benzoxazoles
and benzimidazole analogs [6, 7]. Our previous studies
have demonstrated that one of the main advantages of
a mass spectrometry-based analysis technique for metal-
mediated DNA binding ligands over traditional spec-
troscopic techniques is that information about ligand/
metal and ligand/metal/DNA binding stoichiometries
is obtained. Moreover, typical solution methods to
study the interaction of small molecules with DNA
include absorption and fluorescence spectroscopy, yet
the application of these methods to the types of metal
ion ligands described here is made difficult by the
complex equilibria involved and the effects of metal
ions. The changes in UV/Vis absorbance spectra for
UK-1 and analogs upon DNA binding are subtle com-
pared to those due to metal ion binding. While UK-1
and related 2-hydroxyphenyl benzoxazoles are fluores-
cent, this fluorescence is quenched upon metal ion
Figure 1. Structures of the benzoxazole and ben
Da) in the parentheses. UK-1, 2, 4, and 5 were ebinding, which prohibits the use of the intrinsic fluo-rescence of these compounds in studies of their metal-
mediated DNA binding. Displacement-based DNA
binding assays employing DNA-binding dyes such as
ethidium bromide are also precluded in the study of the
metal-mediated DNA binding of UK-1 and analogs due
to the quenching of the dye’s fluorescence by various
transition metals of interest. Thus, a general and rapid
alternative method, such as ESI-MS, for studying the
metal-mediated DNA binding interactions of these
compounds is needed.
For the present study, anticancer cytotoxicity assays
were also done so that the activities of these analogs
could be correlated to the metal binding behavior
elucidated in the mass spectrometry studies and com-
pared with other previously reported UK-1 analogs. Pre-
vious studies had identified 2 as a simplified analog of
UK-1 that retains the selective cytotoxicity of the natural
product [4]. The analogs of 2 examined here were de-
signed to increase the potential for metal ion complexation
and metal-mediated DNA binding by modifying the ester
side chain of 2, especially through the incorporation of
additional sites for metal ion coordination.
Experimental
The syntheses of 2 and 12 have been previously re-
ported [4, 20]. The synthesis of the benzoxazole analogs
6, 7, 8, 9, 10, and 11 will be reported separately [9]. The
oligodeoxynucleotides (ODNs) used in this study,
dazole ligands. Molecular weights are given (in
ned in a previous study [6].zimid(GCGGGGATGGGGCG), d(CGCCCCATCCCCGC),
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d(GCGGAAATTTGGCG), and d(CGCCAAATTTCCGC)
were purchased from IDT Technologies (Coralville, IA)
as ammonium salts. Duplex DNA was annealed by
preparing equimolar (1 mM) concentrations of the non-
self-complementary ODNs in 250 mM ammonium ace-
tate. Concentrations were verified spectroscopically us-
ing Beer’s law and the extinction coefficients for the
DNA strands provided by the manufacturer. The solu-
tions were heated to 90 °C and allowed to cool to
room-temperature over 7 h. Analytical solutions con-
taining a ligand and metal salt, a ligand and DNA
duplex, or a ligand, metal salt, and DNA duplex were
prepared at equimolar (10 M) concentrations unless
noted otherwise, in 50 mM ammonium acetate solu-
tions with 50% methanol.
The samples were directly infused at 3 L/min into
a Thermo Electron (San Jose, CA) LCQ mass spectrom-
eter. For the DNA binding experiments, the instrument
was operated in the negative ion mode with an electro-
spray voltage of 3.5 kV and a heated capillary temper-
ature of 90 to 110 °C with sheath and auxiliary gas flows
of 40 and 10 arbitrary units, respectively. Ligand/metal
ion solutions were examined in the positive ion mode
using an electrospray voltage of 4.5 kV and the same
heated capillary and gas flow rates used for the solu-
tions containing DNA.
Cytotoxicity was determined using the AlamarBlue
cell viability assay as described previously [4]. Briefly,
aliquots of 100 L cell suspension (1–3  103 cells) were
placed in microtiter plates in an atmosphere of 5% CO2
at 37 °C. After 24 h, 100 L of culture media and 2 L of
the compound in DMSO were added to each well in
duplicate, and the plates incubated an additional 72 h at
37 °C. Compounds, along with Mitomycin-C as a posi-
tive control, were evaluated at final concentrations
ranging from 0.001 to 50 M. Cell viability was deter-
mined by removing the culture media from each well,
and adding 200 L of fresh media and 20 L of
AlamarBlue reagent (Biosource, Camarillo, CA), fol-
lowed by an additional 6 h incubation before fluores-
cence measurement. Fluorescence was measured by a
Beckman Coulter DTX880 plate reader with excitation
at 530 nm and emission at 590 nm. The percent growth
was calculated from the fluorescence data using the eq:
% Growth  100 * (Ft  Fo) ⁄ (Fc  Fo) (1)
where Fo is the averaged measured fluorescent intensi-
ties of AlamarBlue reagent at the time just before the
exposure of the cells to the test substance, Ft is the
averaged measured fluorescent intensities of Alamar-
Blue reagent after 72 h exposure of the cells to the test
substance at a particular concentration, and Fc is the
averaged measured fluorescent intensities of Alamar-
Blue reagent after 72 h exposure of the cells to the
vehicle without the test substance.The concentration of compound required to inhibit
growth by 50% (IC50) was determined by nonlinear
regression fitting the %growth data to the eq:
yMinMaxMin/110[x-log1C50) H] (2)
where x is the compound concentration, y is the %
growth; Min  the minimum response plateau (0%
Growth); Max  the maximum response plateau (100%
growth); H is the Hill slope co-efficient.
Cytotoxicity assays were carried out versus controls
in which DMSO but no benzoxazole ligands were
added to the cells. The concentration of DMSO em-
ployed in these assays does not affect the growth of the
cells.
Results and Discussion
Ligand Binding to Metals
The binding of the benzoxazole ligands with metals
including Mg2, Ca2, Ni2, Cu2, and Zn2 was
screened by ESI-MS to determine the binding prefer-
ences of the analogs and identify the metal ions that are
most promising for enhancing ligand binding. Solutions
containing a metal ion and a ligand were prepared at
equimolar concentrations in the same ammonium ace-
tate buffer used for subsequent DNA binding experi-
ments and analyzed in the positive ion mode (Figure 2).
No complexes were formed between any of the ligands
and either Mg2 and Ca2. Figure 2 shows mass spectra
for solutions containing Mg2 with 8 (Figure 2a) and 9
(Figure 2b), demonstrating the absence of ligand/metal
complexes. To ensure that the binding between the li-
gands and these metals was not concentration-dependant,
the metal ion concentration was increased 10-fold to 100
M; however, no complexation was observed.
These results appear at first to contradict the results
of previous studies in which the analogs of UK-1,
including 2, were found to form complexes with Mg2
[4]. However, the prior binding studies were under-
taken in a solvent containing 100% methanol due to the
low solubility of the early analogs in aqueous buffers
[4]. When methanol was used as a solvent in the current
ESI-MS experiments, 2, 6, 7, 8, 9, 10, and 11 formed
abundant complexes with Mg2 (spectra not shown).
These results demonstrate the importance of the solvent in
the metal ion binding of the benzoxazoles, presumably
due to the differences in metal ion solvation in different
solvents. To maintain consistency with the buffer used for
the DNA binding experiments, the 50 mM ammonium
acetate buffer with 50% methanol (vol/vol) was used for
the remaining metal ion binding experiments.
Ligands 2, 6, 7, 8, 9, 10, and 11 formed complexes
with the divalent transition metals Ni2, Cu2, and to a
lesser degree, Zn2. Typical ligand/metal ion binding
stoichiometries ranged from 1:1 to 2:2, with the 2:2
complexes most likely being dimers of the 1:1 com-
plexes. Ligands with the shorter side chains, 6, 7, and 8
amm
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for a solution containing 8 with Cu2. The short side-
chain ligands were also capable of forming 1:1 com-
plexes, however a water adduct was always bound to
the complex, conceivably to fill the coordination shell of
the metal. The long side-chain compounds, 9, 10, and
11, were able to form abundant 1:1 complexes without a
solvent adduct as demonstrated by the spectrum of 9
with Cu2 shown in Figure 2d. Likely, the long side
chain is able to wrap partially around the metal ion
upon binding, thereby filling the coordination shell
without addition of solvent molecules.
The only benzoxazole ligand that did not form
complexes with Ni2, Cu2, and Zn2 was 12 (spectra
not shown). This compound is the only analog exam-
ined in this study that contains a methyl ester group
rather than a hydroxyl group on the phenyl moiety of
the compound. The 2-(2=-hydroxylphenyl)benzoxazole
moiety is also present in synthetic metal ion chelators
[21, 22], and is believed to play a key role in the metal
ion chelation of the compounds [3]. The lack of metal
ion binding observed by 12 in the ESI-MS experiments
further implicates the role of the hydroxyl phenyl group
in the metal ion binding of the benzoxazoles and makes
12 a good negative control compound for ligand/metal
binding examined by ESI-MS.
The collisionally activated dissociation (CAD) mass
Figure 2. ESI-mass spectra for solutions conta
Mg2, (b) 9 and Mg2, (c) 8 and Cu2, and (d) 9 a
at equimolar (10 M) concentrations in 50 mMspectra of the ligand/metal complexes were also exam-ined by ESI-MS. Upon collisional activation, the 2:1
complexes containing 6, 7, and 8 dissociate via the
ejection of a neutral ligand with the rapid adduction of
a water molecule (always present in the trap in trace
amounts) to the resulting 1:1 complex (spectra not
shown). This is the same fragmentation pattern re-
ported for complexes containing the anti-cancer analog
2 with Cu2 and Ni2 [6]. When the resulting 1:1
complexes were subjected to a second stage of CAD
(MS3), the complexes did not undergo further observ-
able fragmentation. Likely, the attached water molecule
is dislodged during collisional activation, but then
rapidly reattaches before ion detection. This type of
solvent adduction process has been commonly ob-
served for transition-metal complexes in a quadrupole
ion trap [23–27]. This was the same fragmentation
pattern observed for the dissociation of the water-
solvated 1:1 complexes containing 6, 7, and 8 and a
transition-metal.
Collisional activation of the 2:1 benzoxazole:metal
complexes that contained the ligands with longer side
chains, 9, 10, and 11, showed dissociation via the loss of
one ligand, leaving 1:1 complexes (spectra not shown).
Upon MS3, these 1:1 complexes produced different
fragmentation pathways that were dependent on the
ligand. Complexes containing 7 and 9, the ligands with
a polyethylene glycol side chain, dissociated via the loss
benzoxazole ligands and metal ions: (a) 8 and
u2. Solutions contained a ligand and metal salt
onium acetate solutions with 50% methanol.ining
nd Cof small portions of the side chain, such as C2H4O,
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the ligand. These losses are not observed for 10, which
contains a six carbon alkyl chain with a terminal hy-
droxyl group. Instead, the 1:1 complexes containing 10
dissociate via the loss of the metal ion with the sponta-
neous adduction of methanol or water. In general, these
initial ESI-MS experiments not only revealed that Ni2,
Cu2, and Zn2 are apparently the favored metals for
ligand binding, but also showed differences in the
preferred binding stoichiometries and fragmentation
patterns for complexes containing ligands with long
versus short side chains.
DNA Binding of the Ligands Without Metals
In previous ESI-MS studies, benzoxazole and benz-
imidazole ligands that exhibited antibacterial activity
were found to bind to DNA in the absence of metal
cations, while compounds exhibiting anticancer ac-
tivity, notably UK-1 and 2, only formed complexes
with duplex DNA in a metal-mediated manner.
Therefore, the DNA binding of the new analogs of
2 (Figure 1) in the absence of metal cations was of
great interest and was examined by ESI-MS in the
present study. Three non-selfcomplementary DNA
duplexes, d(GCGGGGATGGGGCG/CGCCCCATC-
CCCGC), d(GCGGGAATTGGGCG/CGCCCAATTC-
Figure 3. ESI-mass spectra of solutions contain
(f) 10. Solutions contained a ligand, metal salt, an
in 50 mM ammonium acetate solutions with 50% meCCGC), and d(GCGGAAATTTGGCG/CGCCAAATT-
TCCGC), were used for the initial screening study. The
duplex sequences were selected to have different de-
grees of G/C and A/T base pair composition to inves-
tigate possible sequence preferences of the ligands.
Solutions containing one ligand and one duplex at
equimolar (10 M) concentration were prepared in 50
mM ammonium acetate with 50% methanol. The high
methanol composition was necessary to ensure the
ligands remained soluble in the analytical solutions. To
allow for comparison of the DNA binding of the new
analogs with 2, experiments involving 2 were included
in the present study to maintain consistency with the
earlier study [6].
As demonstrated by the series of spectra shown in
Figure 3 for solutions containing one of six ligands
with d(GCGGGAATTGGGCG/CGCCCAATTCCCGC),
three of the ligands, 9 (Figure 3d), 10 (Figure 3e), and 11
(Figure 3f) were found to form low abundance com-
plexes with 1:1 ligand/DNA binding stoichiometries,
while 6 (Figure 3a), 7 (Figure 3b) and 8 (Figure 3c) did
not form any complexes detectable by ESI-MS. As
expected, 2 likewise did not bind to DNA in the absence
of metal ions (spectra not shown). The binding results
of the ligands with the other two duplexes, d(GCGGG-
GATGGGGCG/CGCCCCATCCCCGC) and d(GCG-
GAAATTTGGCG/CGCCAAATTTCCGC), were simi-
uplex 3/4 and (a) 6, (b) 7, (c) 8, (d) 11, (e) 9, and
A duplex at equimolar (10 M) concentrationsing d
d DNthanol.
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ligands do not have significant sequence selectivities.
The ligands that do bind to the duplex all contain ester-
or amide-linked side chains that are longer than those
compounds that did not bind to duplex DNA, suggest-
ing the side chains could play a role in promoting
nonmetal mediated DNA binding of the benzoxazoles.
The nonmetal-mediated binding of 9, 10, and 11
differs from that of the antibacterial ligands 4 and 5
examined in our previous study. The complexes formed
by 4 and 5 had greater relative abundances, and the
binding stoichiometries ranged from 1:1 to 3:1 and were
highly dependent on ligand concentration [6]. The
binding behavior of ligands 4 and 5 was similar to that
of commercial intercalators examined in previous
ESI-MS studies [17, 28]. While 9, 10, and 11 formed
complexes with duplexes without metals, the binding
stoichiometries never exceed 1:1, and their relative
abundances are low.
DNA Binding of the Ligands with Metals
Metal cations are documented to play a key role in the
DNA binding of UK-1 and 2; the 1:1 binding of divalent
metal ions by these ligands can result in cationic com-
plexes with increased electrostatic attraction towards
DNA. In analogy with the magnesium-dependent
DNA binding by quinobenzoxazines [29], the metal
ion-mediated binding of UK-1 and analogs with DNA
may involve shared coordination of the ligand and
phosphate groups on the DNA with the metal ion. This
metal-mediated binding behavior is thought to be re-
lated to the anti-cancer activity of these ligands over
other nonmetal-mediated benzoxazole and benzimid-
azole compounds. Previous studies of the solution
metal ion binding ability of UK-1 and analogs had
indicated that Mg2 and Zn2 were implicated in the
metal-mediated DNA binding by these compounds
[4], while in ESI-MS studies Ni2 , Co2 , and Zn2 
promoted the greatest duplex binding for UK-1 [7],
and the duplex binding of 2 was found to be medi-
ated by Ni2  [6].
To determine if the binding of the new benzoxazole
ligands is also metal-mediated, ESI-MS experiments
were undertaken for solutions containing equimolar (10
M) concentrations of a benzoxazole ligand, duplex
d(GCGGGAATTGGGCG/CGCCCAATTCCCGC), and
a metal salt. Based on the first section of results de-
scribed above, only the metals that were found to form
complexes with the ligands, Ni2, Cu2, and Zn2, were
used in this phase of the study. The most significant
enhancement in duplex/ligand binding was observed
with Cu2 as demonstrated by the spectra shown in
Figure 4, which correspond to solutions containing
Cu2, the duplex and either 6 (Figure 4a), 7 (Figure 4b),
or 8 (Figure 4c). While none of these three ligands
bound DNA in the absence of metal ions (i.e., Figure 3a,
b, and c), complexation is observed for all three in the
presence of copper, with the most significant degree ofbinding observed for 7 and 8. Complexes containing
ligand/metal/DNA binding stoichiometries of 1:1:1
and 2:2:1 were observed for 7 and 8, while only low
abundance 1:1:1 were formed with 6. Similar results
were obtained for 2 (spectra not shown). The ions that
are not labeled in Figure 4 correspond to sodium
adducts of the DNA and ligand/Cu2/DNA com-
plexes, with the source of sodium contamination likely
being the benzoxazole solutions.
While 9, 10, and 11 were found to bind to duplex
DNA even in the absence of metal cations, their binding
was enhanced in the presence of Cu2, most signifi-
cantly for 9 and 10 (spectra not shown). To compare the
changes in the degree of ligand binding upon addition
of the metal salt, the fraction of bound DNA values
were calculated by expressing the sum of the abun-
dances of all ions attributed to DNA/ligand complexes
as a fraction of the total abundances of all DNA-
containing ions (both free DNA and DNA/ligand com-
plexes) as has been previously reported for other
ligand/DNA complexes [30]. The abundances for all of
the sodium adducts associated with each complex were
included in the calculation, and only ions in the
5-charge state were used since this was the dominant
charge state in the mass spectra. Inclusion of the abun-
dances for the 6-charge state does not change the
results. The increase in the extent of binding by 9, 10
and 11 is reflected in the fraction of bound DNA values
summarized in Table 1. The results here and summa-
rized in Table 1 demonstrate that Cu2 has the greatest
impact on ligand binding, enhancing the binding of 9,
10, and 11, and promoting binding by the other ligands
with the most dramatic metal-mediated behavior seen
for 7 and 8, and to a lesser degree, 6.
In general, Ni2 had a small impact on ligand
binding as demonstrated by the spectra shown in
Figure 5. Extensive binding of Ni2 to the duplex DNA
is observed in Figure 5, but this does not translate into
an enhancement of ligand binding. Ligand 8 was the
only new analog that exhibited binding in the presence
of Ni2 yet did not bind to DNA without metal ions, as
shown in Figure 5c. A low abundance 1:1:1 complex
containing 8 is formed (Figure 5c), but with lower
abundance relative to the complexes formed by 8 in the
presence of Cu2 (Figure 4c). The duplex binding of 9
was also enhanced in the presence of Ni2 (spectra not
shown). For 9, the fraction of bound DNA increased
from 0.17 in the absence of metal ions to 0.34 in the
presence of Ni2 (Table 1). Experiments with 2 con-
firmed the results of our previous study that found the
binding of the ligand to be Ni2-mediated. The fraction
of bound DNA values based on the 2/Ni2/DNA
complexes was 0.18, which is similar to that of the
8/Ni2/DNA complexes, 0.14.
Figure 5a and b show that neither 6 nor 7 bound to
the DNA with Ni2, nor did Ni2 enhance the binding
of 10 or 11 (spectra not shown). As summarized in Table
1, the fraction of bound DNA values for 10 and 11 in the
absence of metal ions were 0.09 and 0.20, respectively
hano
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ligand/Ni2/DNA complexes, the relative abundances
of these complexes were either the same as or lower
than the abundances of the complexes formed in the
absence of metal ions. This is reflected in the fraction of
bound DNA values for solutions containing the ligands
with Ni2 and DNA which were calculated to be 0.13
for 10 and 0.08 for 11.
Zn2 did not have a significant impact on the ben-
zoxazole ligand binding to DNA. Zn2 did not promote
DNA binding by 6, 7, 8, or 2, the ligands that likewise
did not bind to DNA in the absence of metals (spectra
not shown). Ligand 10 formed 1:1:1 ligand/Zn2/DNA
complexes, however the fraction of bound DNA value
for ligand binding in the presence of zinc was 0.17, which
is not significantly different than it was in the absence of
metal, 0.20 (spectra not shown). The DNA binding of 9
and 11 was enhanced by Zn2, as indicated by an increase
in their fraction of bound DNA values (spectra not
shown). For 11, the fraction of bound DNA without metals
was 0.09 and in the presence of Zn2 it increased to 0.17,
while the values increased from 0.17 to 0.27 for 9.
Aside from 2, the ligands displaying the most pro-
Figure 4. ESI-mass spectra of solutions contain
Solutions contained a ligand, metal salt and DN
mM ammonium acetate solutions with 50% metnounced metal-mediated DNA binding based on theESI-MS results are 7 and 8. The binding of 6 was also
mediated by Cu2, however the complexes formed by
the ligand are lower in relative abundance than those
formed by 7 and 8. This result is somewhat unsurpris-
ing due to the similarities in the structures of 2, 7, and
8. The ester linkage of 2 is changed to an amide-linkage
Table 1. Fraction of bound DNA valuesa for the benzoxazole
ligands and d(GCGGGAATTGGGCG/CGCCCAATTCCCGC)
with Ni2, Cu2, or Zn2 and in the absence of metals.
Solutions contained equimolar (10 M) concentration of ligand,
DNA, and, where appropriate, metal ionb
Ligand No metal Ni2 Cu2 Zn2
2 0 0.18 0.17 0
6 0 0 0.14 0
7 0 0 0.40 0
8 0 0.14 0.27 0
9 0.17 0.34 0.27 0.27
10 0.20 0.13 0.32 0.17
11 0.09 0.08 0.15 0.17
aAll values 0.05. This error represents the largest standard deviation
for experiments that were repeated on three separate days.
b
uplex 3/4 and Cu2 with (a) 6, (b) 7, and (c) 8.
plex at equimolar (10 M) concentrations in 50
l.ing d
A duAll solutions were prepared in a solvent composed of 50 mM ammo-
nium acetate with 50% methanol (vol/vol).
hano
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binding, copper had a more positive impact on 8
binding than it did on 2. Likewise, Ni2 promoted
greater binding for 2 than it did for 8. This difference
may result from the preferential coordination of Cu(II)
to nitrogen atoms over oxygen atoms [31]. Similar
differences can be seen for the binding of 7, which also
has an amide-linked side chain that is extended by two
carbon atoms compared to 8 and 2. Compared with 2, 7
demonstrates greater DNA binding with copper and no
binding with Ni2.
While the longer side chains of 9, 10, and 11 enhance
nonmetal-mediated DNA binding, they tend to pre-
clude the dramatic metal-mediated DNA binding
behavior observed for the ligands with the shorter side
chains. The longer side chains of the ligands are be-
lieved to enhance the metal binding of the ligands by
wrapping around and coordinating to the metals. The
ester-linked polyethylene glycol side chain of 9 pro-
duced the best enhancement of metal-mediated bind-
ing, as all three metal ions, Ni2, Cu2, and Zn2,
increased the binding of the ligand to DNA relative to
the binding in the absence of any metal. The results for
11, with the shorter, amide-linked polyethylene glycol
Figure 5. ESI-mass spectra of solutions contain
Solutions contained a ligand, metal salt and DN
mM ammonium acetate solutions with 50% metside chain were not as favorable. While the binding wasenhanced by Cu2 and Zn2, the overall fraction of
bound DNA values were generally lower than the
values for the other ligands in the presence of metals.
With an amide-linked side chain that did not contain
ethylene glycol groups, the binding of 10 was only
enhanced by Cu2. The binding results of the ligands
with the longer side chains suggests that the longer,
polyethylene glycol side chain of 9 is the most favorable
for overall metal-mediated binding.
Cytotoxicity Assays
There are some interesting correlations between the
degree of metal-mediated binding behavior of the ben-
zoxazole ligands determined by ESI-MS and their cyto-
toxicity to two cancer cell lines. As summarized by the
IC50 values shown in Table 2, the new ligands with the
greatest cytotoxicity against the A549 lung cancer cell
line were 7, 8, and 9, all having IC50 values that were
similar to 2. Both 7 and 8 exhibited the most dramatic
degree of metal-mediated DNA binding as their frac-
tion of bound DNA values increased from 0 in the
absence of metal ions to 0.40 and 0.27, respectively, in
the presence of Cu2. Ligand 8 was also found to form
uplex 3/4 and Ni2 with (a) 6, (b) 7, and (c) 8.
plex at equimolar (10 M) concentrations in 50
l.ing d
A ducomplexes in the presence of Ni2. While 9 was not a
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the most consistent and dramatic enhancement in DNA
binding in the presence of metal ions compared to all
the ligands that bound to DNA in the absence of metal
ions.
Ligands 8 and 9 also showed cytotoxicity against the
MCF7 breast cancer cell lines with IC50 values of 10  8
M and 13  2 M, respectively. Both of these values
are on par with the IC50 value of 2 (4  2 M).
Interestingly, 7, which showed activity against A549
cells comparable to that of 2 was relatively inactive
against MCF7 cells (IC50  30  10 M), and 6, which
was relatively inactive against A549 cells, retained some
activity against MCF7 cells (IC50  15  5 M). At this
point the reasons for these differences are unclear, but
we note that of the two analogs of 2 that incorporate the
most conservative structural changes, 6 and 8, only 8
demonstrates enhanced metal-mediated DNA binding
relative to 2, and this analog also displays the most
comparable cytotoxicity against both cancer cell lines
relative to 2. Ligand 9 also demonstrated good cytotoxic
activity, and while it was not a truly metal-mediated
DNA binder, its DNA complexation was consistently
enhanced by the presence of Cu2, Ni2, and Zn2. In
contrast, compound 12, which does not bind metal ions,
was the only compound in this series that did not
display cytotoxicity towards either cell line.
Conclusions
The correlation between significant metal-mediated or
metal-enhanced binding determined by ESI-MS and
anticancer activity of the benzoxazoles ligands assessed
by cytotoxicity assays is demonstrated in this study.
ESI-MS experiments reveal that Cu2 and Ni2 form the
most abundant complexes with 6, 7, 8, 9, 10, and 11,
while less abundant complexes are formed with Zn2.
For the complexes containing short side chains, 6, 7, and
8, 2:1 ligand/metal ion binding stoichiometries were
predominant, whereas the compounds with longer side
chains, 9, 10, and 11, formed abundant 1:1 complexes.
DNA binding experiments reveal that the analogs with
longer side chains formed complexes with duplex DNA
in the absence of metal ions, while those with shorter
Table 2. IC50 values (in M) for the benzoxazole compounds
against the A549 (lung cancer) and MCF7 (breast cancer) cell
lines
Ligand A549 MCF7
2 12  3 4  2
6 40  10 15  5
7 14  4 30  10
8 11  1 10  8
9 11  1 13  2
10 39  11 31  7
11 41  17 50
12 50 50side chains did not.Of the ligands that did not bind to duplex DNA in
the absence of metal ions, the DNA binding by 7 and 8
was enhanced most dramatically by Cu2. Ni2 influ-
enced duplex binding for 8 and 2, and enhanced the
binding by 9. The metal ion with the least substantial
effect was Zn2, which only enhanced the binding of 9
and 11, two ligands that formed complexes with DNA
regardless of the presence of metals.
Of the compounds examined in this study, both 7
and 8 were also found to be the most cytotoxic against
the A549 lung cancer cell line and 8 demonstrated
moderate cytotoxicity against MCF7 breast cancer cells.
Metal ions also enhanced the DNA binding of the
ligands with the long side chains, most notably for 9,
which also exhibited the highest level of cytotoxicity of
the long side-chain compounds.
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